Pseudomonas multicomponent vaccine in major burn patients
Mizuno, H.; Ashikawa, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 49(10): 2425-2430
1991
ISSN/ISBN: 0047-1852 PMID: 1749100 Document Number: 374936
Document emailed within 1 workday
Related Documents
Aoi, Y.; Noda, H.; Yanagawa, R.; Homma, J.Y.; Abe, C.; Morihara, K.; Goda, A.; Takeuchi, S.; Ishihara, T. 1979: Protection against hemorrhagic pneumonia of mink by Pseudomonas aeruginosa multicomponent vaccine Japanese Journal of Experimental Medicine 49(3): 199-207Kalantar, E.; Taherzadeh, S.; Ghadimi, T.; Soheili, F.; Salimizand, H.; Hedayatnejad, A. 2012: Pseudomonas aeruginosa, an emerging pathogen among burn patients in Kurdistan Province, Iran Southeast Asian Journal of Tropical Medicine and Public Health 43(3): 712-717
Stanislavskiĭ, E.S.; Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Chekan, L.V. 1981: Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 37-40
Mansurova, N.L.; Egorova, N.B.; Kaverina, K.G.; Poliachenko, V.M.; Lobova, E.A. 1991: The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 39-41
Muangman, P.; Muangman, S.; Suvanchote, S.; Benjathanung, R. 2007: Abdominal compartment syndrome monitoring in major burn patients with Siriraj device catheter Journal of the Medical Association of Thailand 90(2): 384-390
Egorova, N.B.; Semenov, B.F.; Kurbatova, E.A.; Iastrebova, N.E.; Poddubikov, A.V.; Efremova, V.N.; Semenova, I.B. 2002: Dynamics of autoantibodies in elderly persons in the process of vaccination with Grippol and multicomponent vaccine VP-4 Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 29-35
Ostrovskaia, R.U.; Liapina, L.A.; Pastorova, V.E.; Mirzoev, T.K.; Gudasheva, T.A.; Seredenin, S.B.; Ashmarin, I.P. 2002: Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine Eksperimental'naia i Klinicheskaia Farmakologiia 65(2): 34-37
Cryz, S.J.; Lang, A.; Rüdeberg, A.; Wedgwood, J.; Que, J.U.; Fürer, E.; Schaad, U. 1997: Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine Behring Institute Mitteilungen 1997(98): 345-349
Kochetkova, V.A.; Moskovtseva, R.L.; Mamontov, A.S. 1987: A complex vaccine in the prevention of staphylococcal, Pseudomonas aeruginosa and Proteus infections in esophageal cancer patients Voprosy Onkologii 33(2): 58-63
Bukowska, D.; Serafińska, D.; Zietkiewicz, W.; Rudowski, W.; Hoffman, S.; Uszyński, H.; Molski, M.; Hess, C.; Jonecko, A.; Popiel, D. 1986: Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland Polski Tygodnik Lekarski 41(49): 1549-1552
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18
Postel, J.; Allgöwer, M.; Burkhart, F.; Müller, W.; Städtler, K.; Schoenenberger, G.A. 1974: Pathogenetic and immunotherapeutic significance of a cutaneous burn toxin in experimental pseudomonas infection Helvetica Chirurgica Acta 41(1-2): 7-11
Kreĭnin, L.S.; Egorova, N.B.; Stanislavskiĭ, E.S.; Kaverina, K.G.; Levina, L.A. 1983: Combined Staphylococcus-Proteus-Pseudomonas vaccine. II. the toxicity of the vaccine in "chronic" experiments and its ability to protect animals against Proteus and Staphylococcus infections Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 87-92
Keeling, P.; Winchurch, R.A.; Munster, A.M. 1979: Immunopotentiation following major burn trauma Surgical Forum 30: 50-52
Tymonová, J.; Adámková, M.; Torsová, V.; Kadlcík, M.; Jackanin, J.; Crkvenjas, Z. 2008: Catheter-related infections in burn patients at the Burn Centre of the University Hospital in Ostrava Acta Chirurgiae Plasticae 50(1): 23-26
Nakamoto, K.; Mozaffari, F.B. 2019: Discrepancies in Burn Size Estimates in Patients Referred to a Burn Center in Huntington, West Virginia American Surgeon 85(8): E411-E412
Okada, K.; Kawaharajo, K.; Kasai, T.; Homma, J.Y. 1980: Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection Japanese Journal of Experimental Medicine 50(1): 53-61
Sato, H.; Diena, B.B. 1974: A polyvalent Pseudomonas vaccine Revue Canadienne de Biologie 33(2): 93-97
Di Quirico, R.; Di Tano, V.; Cornacchia, R.; Orfanelli, R.; Leonio, L.; Bindi, F. 2008: Major burn: proposal of synthetic prehospital and hospital protocols Il Giornale di Chirurgia 29(4): 177-179
Eriksson, E.; Robson, M.C. 1977: New pathophysiologic mechanism explaining the generalized edema after a major burn Surgical Forum 28: 540-543